Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 3486-66-6 Chemical Structure| 3486-66-6

Structure of Coptisine
CAS No.: 3486-66-6

Chemical Structure| 3486-66-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Coptisine is a protoberberine isoquinoline alkaloid isolated and purified from the herbs of Chelidonium majus L., which can increases cell viability based on its reversal effect on the enhanced activity of Indoleamine 2,3-dioxygenase .

Synonyms: Coptisin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Coptisine

CAS No. :3486-66-6
Formula : C19H14NO4
M.W : 320.32
SMILES Code : C12=CC3=CC=C4C(OCO4)=C3C=[N+]1CCC5=C2C=C(OCO6)C6=C5
Synonyms :
Coptisin
MDL No. :MFCD03792689
InChI Key :XYHOBCMEDLZUMP-UHFFFAOYSA-N
Pubchem ID :72322

Safety of Coptisine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H311-H331
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
NCI-H1299 cells 10 μM or 20 μM 24 h COP significantly reduced the expression of ATF4 induced by glutamine restriction, leading to substantial inhibition of cancer cell proliferation. Adv Sci (Weinh). 2024 Sep;11(35):e2401748
NCI-H460 cells 10 μM or 20 μM 24 h COP significantly reduced the expression of ATF4 induced by glutamine restriction, leading to substantial inhibition of cancer cell proliferation. Adv Sci (Weinh). 2024 Sep;11(35):e2401748
Helicobacter pylori clinical isolates 25-50 μg/mL 3 days To evaluate the antibacterial activity of Coptisine against clinical isolates, results showed that the MICs of Coptisine against clinical isolates were either 25 or 50 μg/mL J Enzyme Inhib Med Chem. 2018 Dec;33(1):1362-1375
Helicobacter pylori standard strain NCTC 11637 25 μg/mL 3 days To evaluate the antibacterial activity of Coptisine against H. pylori, results showed that the MIC of Coptisine against NCTC 11637 strain was 25 μg/mL J Enzyme Inhib Med Chem. 2018 Dec;33(1):1362-1375
Hep3B cells 50 µM 24 h Coptisine markedly increased DNA damage and apoptotic cell death, which was associated with induction of death receptor proteins. Coptisine also significantly upregulated expression of proapoptotic Bax protein, downregulated expression of anti-apoptotic Bcl-2 protein, and activated caspase-3, -8, and -9. In addition, coptisine remarkably increased the generation of reactive oxygen species (ROS), loss of mitochondrial membrane potential (MMP), and release of cytochrome c into the cytoplasm. Int J Mol Sci. 2020 Jul 31;21(15):5502
MOLM-13 cells 0–20 μM 12 h To evaluate the inhibitory activity of Coptisine on METTL3 and its effect on m6A modification levels. Results showed that Coptisine dose-dependently decreased m6A levels of mRNAs. Adv Sci (Weinh). 2024 Jul;11(26):e2308786
BEAS-2B 10 μM 24 h no significant effect on KRAS mRNA levels Nat Commun. 2022 Oct 12;13(1):6016
A549 10 μM 24 h significantly lowered KRAS mRNA levels Nat Commun. 2022 Oct 12;13(1):6016
H460 10 μM 24 h significantly lowered KRAS mRNA levels Nat Commun. 2022 Oct 12;13(1):6016

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice H460 xenograft tumor model Intraperitoneal injection 100 mg/kg Every other day for two weeks COP significantly enhanced the inhibitory effect of glutamine-restrictive therapy on tumor growth and effectively disrupted the GCN2-ATF4-ASCT2 axis. Adv Sci (Weinh). 2024 Sep;11(35):e2401748
Mice Periodontitis models Local injection 20 μM Daily, until the experimental endpoint To evaluate the therapeutic effect of Coptisine on periodontitis. Results showed that Coptisine significantly alleviated inflammatory periodontal bone loss and reduced the expression of IL-1β and GSDMD. Adv Sci (Weinh). 2024 Jul;11(26):e2308786

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.12mL

0.62mL

0.31mL

15.61mL

3.12mL

1.56mL

31.22mL

6.24mL

3.12mL

References

 

Historical Records

Categories